Extra blood tests could spot thyroid issues in preemies sooner
NCT ID NCT07425028
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will check if doing two blood tests instead of one can better detect congenital hypothyroidism in premature babies born before 32 weeks. Researchers will follow 1,600 newborns in France, testing them within 15 days of birth and again at 2 years if needed. The goal is to see if European recommendations for repeat screening catch more cases than the current single-test approach.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to improved screening guidelines that catch congenital hypothyroidism earlier in premature babies, preventing developmental delays.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures how many babies have the condition, so it won't directly improve outcomes. The results may not change current practice if the extra tests don't prove useful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,600 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2027
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Premature newborns born in maternity wards included in the study
- Ages
-
23 to 32 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newborns born prematurely between 23 and 32 weeks of gestational age (up to 31 weeks and 6 days), both female and male, of all ethnic origins, regardless of birth weight, and including all other pathologies. * Newborns whose parents have given their non-opposition consent. Exclusion Criteria: * Newborns born who leave the region before day 15. * Newborns who die before 15 days of age. * Newborns whose parents are not affiliated with the social security system.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital hypothyroidism are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Chu de Lille
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher starting dose of thyroid hormone speed up recovery in newborns?
- Newborn screening study aims to catch rare diseases at birth
- New study to map normal thyroid size in italian newborns
- New liquid thyroid drug tested in infants: could it be better?
- DNA detective work: why some babies have lifelong thyroid problems
- New study eyes hidden developmental hurdles in hypothyroid infants